Skip to main content
main-content

Diabetes

Latest articles

01-10-2021 | Diabetes | News | Article

Higher risk for incident CV, renal disease with type 1 vs type 2 diabetes

People with type 1 diabetes have a greater risk for incident cardiovascular and renal disease than those with type 2 diabetes, suggest findings from a French nationwide observational study presented at the virtual 57th EASD Annual Meeting.

01-10-2021 | Diabetes | News | Article

Use of SGLT2 inhibitors beneficial in older adults with type 2 diabetes

Among older people with type 2 diabetes, use of SGLT2 inhibitors is associated with improved glycemic control and a favorable safety profile, suggests research reported at the virtual 57th EASD Annual Meeting.

01-10-2021 | Diabetes | News | Article

LIRALUNG: Liraglutide may improve some measures of lung function in type 2 diabetes

Findings from a phase 3 randomized crossover trial suggest that 7 weeks of treatment with liraglutide may improve forced vital capacity among people with type 2 diabetes and impaired lung function.

01-10-2021 | Diabetes | News | Article

ADA/EASD publish consensus report on type 1 diabetes management

The newly published ADA/EASD consensus report on the management of type 1 diabetes provides a comprehensive overview of the care required to help people with the condition live a full and healthy life.

01-10-2021 | Diabetes | News | Article

African–Caribbean ethnicity may predispose to retinopathy in type 1 diabetes

African–Caribbean ethnicity may be a predisposing factor for sight-threatening diabetic retinopathy in people with type 1 diabetes, research suggests.

01-10-2021 | Diabetes | News | Article

Liraglutide treatment may reduce cardiac adipose tissue

Treatment with the GLP-1 receptor agonist liraglutide is associated with a reduction in cardiac adipose tissue volume among people with type 2 diabetes, suggests a secondary analysis of data from the LiraFlame trial.

30-09-2021 | Diabetes | News | Article

Insulin resistance linked to arterial stiffness in type 1 diabetes

Researchers have identified an association between insulin resistance and arterial stiffness among people with type 1 diabetes.

30-09-2021 | Diabetes | News | Article

AF, PAD, diabetes prevention data reported from DAPA-CKD

The latest DAPA-CKD data show the large absolute benefits of dapagliflozin treatment in people with peripheral artery disease or atrial fibrillation, and that the medication may reduce the risk for type 2 diabetes in people with initial prediabetes.

29-09-2021 | Diabetes | News | Article

TriMaster supports precision medicine strategy for type 2 diabetes treatment intensification

Findings from the TriMaster trial suggest that stratification of people with type 2 diabetes based on clinical features may help to guide the choice of second- or third-line drug for those who require treatment intensification after metformin.

29-09-2021 | Diabetes | News | Article

Intra-organ fat reduction parallels type 2 diabetes remission in lean people

Outwardly lean people who have type 2 diabetes have increased intra-organ fat, reductions in which occur in line with weight loss-induced diabetes remission, say researchers.

29-09-2021 | Diabetes | News | Article

No difference in hypoglycemia duration with insulin icodec vs insulin glargine in type 2 diabetes

People with type 2 diabetes receiving the once-weekly basal insulin analog insulin icodec have similar hypoglycemic episode durations to those given insulin glargine, regardless of titration algorithm, initial loading dose, or prior insulin use, study findings indicate.

29-09-2021 | Diabetes | News | Article

Obstructive sleep apnea risk increased in type 1 diabetes

People with type 1 diabetes have an increased risk for developing obstructive sleep apnea, researchers have reported at the virtual 57th EASD Annual Meeting.

29-09-2021 | Diabetes | News | Article

Age at type 1 diabetes diagnosis is decreasing within families

The age at diagnosis of type 1 diabetes has decreased substantially across successive generations, show study findings presented at the virtual 57th EASD Annual Meeting.

29-09-2021 | Diabetes | News | Article

Non-dipping of nocturnal blood pressure linked to adverse outcomes in type 1 diabetes

People with type 1 diabetes who do not experience a nocturnal reduction in blood pressure may have an elevated risk for mortality and adverse kidney events, research suggests.

29-09-2021 | Diabetes | News | Article

Heterogeneous CVD risk demonstrated in people with type 2 diabetes

The 10-year and lifetime CVD risk of people with type 2 diabetes varies greatly, with the highest risk seen in those with prior CVD, suggests an analysis of data from the CAPTURE study.

29-09-2021 | Diabetes | News | Article

SUSTAIN 10 analysis supports additive benefits of GLP-1 receptor agonists, SGLT2 inhibitors

A post-hoc analysis of SUSTAIN 10 indicates that people with type 2 diabetes stand to gain from GLP-1 receptor agonist use even if they are already using an SGLT2 inhibitor.

28-09-2021 | Diabetes | News | Article

Hypoglycemia may initiate ‘cascade of negative consequences’

Findings from the Hypo-RESOLVE study suggest that exposure to hypoglycemia is associated with subsequent negative clinical outcomes in people with diabetes, supporting a key role for hypoglycemia prevention.

28-09-2021 | Diabetes | News | Article

DKA presentation similar for type 1 and type 2 diabetes

Diabetic ketoacidosis is three times more common with type 1 diabetes than with type 2 diabetes, but episode presentation and severity are similar between the two groups, show data presented at the virtual 57th EASD Annual Meeting.

28-09-2021 | Diabetes | News | Article

Real-world GLP-1 receptor agonist persistence improved with weekly formulation

The real-world STAY study suggests that people take GLP-1 receptor agonists more consistently and for longer if given a weekly rather than daily formulation.

28-09-2021 | Diabetes | News | Article

Poor hypoglycemia awareness ‘highly prevalent’ in children, young people with type 1 diabetes

Impaired hypoglycemia awareness is present in a substantial proportion of children and young people with type 1 diabetes and is associated with an increased risk for severe hypoglycemia, suggests research presented at the virtual 57th EASD Annual Meeting.